Lineage Cell Therapeutics, Inc. (LCTX.TA)

ILA 191.3

(5.4%)

Total Debt Summary of Lineage Cell Therapeutics, Inc.

  • Lineage Cell Therapeutics, Inc.'s latest annual total debt in 2023 was 2.95 Million USD , down -24.23% from previous year.
  • Lineage Cell Therapeutics, Inc.'s latest quarterly total debt in 2024 Q2 was 2.95 Million USD , down -9.31% from previous quarter.
  • Lineage Cell Therapeutics, Inc. reported annual total debt of 3.89 Million USD in 2022, up 39.04% from previous year.
  • Lineage Cell Therapeutics, Inc. reported annual total debt of 2.8 Million USD in 2021, down -15.14% from previous year.
  • Lineage Cell Therapeutics, Inc. reported quarterly total debt of 2.95 Million USD for 2024 Q2, down -9.31% from previous quarter.
  • Lineage Cell Therapeutics, Inc. reported quarterly total debt of 2.95 Million USD for 2023 FY, down -24.23% from previous quarter.

Annual Total Debt Chart of Lineage Cell Therapeutics, Inc. (2023 - 1991)

Historical Annual Total Debt of Lineage Cell Therapeutics, Inc. (2023 - 1991)

Year Total Debt Total Debt Growth
2023 2.95 Million USD -24.23%
2022 3.89 Million USD 39.04%
2021 2.8 Million USD -15.14%
2020 3.3 Million USD -36.11%
2019 5.16 Million USD 128.17%
2018 2.26 Million USD 47.75%
2017 1.53 Million USD -61.5%
2016 3.98 Million USD -21.97%
2015 5.1 Million USD 868.3%
2014 527 Thousand USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD -100.0%
2008 1.88 Million USD 163.17%
2007 716.53 Thousand USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD -100.0%
2003 2.68 Million USD 23.82%
2002 2.16 Million USD 25.28%
2001 1.73 Million USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%
1996 - USD 0.0%
1995 - USD 0.0%
1994 - USD 0.0%
1993 - USD 0.0%
1992 - USD 0.0%
1991 - USD 0.0%

Peer Total Debt Comparison of Lineage Cell Therapeutics, Inc.

Name Total Debt Total Debt Difference
Matricelf Ltd 1.24 Million ILA -137.681%